BOTHELL, Wash.--(BUSINESS WIRE)--Cardiac Science Corporation (NASDAQ:CSCX), a global leader in advanced cardiac diagnosis, resuscitation, rehabilitation, and informatics products, announced revenue for the quarter ended June 30, 2008 was $52.1 million, an increase of 16% over the prior year period.
